Division of Gastroenterology, Department of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada.
Dis Esophagus. 2010 Sep;23(7):554-60. doi: 10.1111/j.1442-2050.2010.01065.x. Epub 2010 May 4.
Diffuse esophageal spasm is a primary esophageal motility disorder. The prevalence is 3-10% in patients with dysphagia and treatment options are limited. This review summarizes the treatment of diffuse esophageal spasm, including pharmacotherapy, endoscopic treatment, and surgical treatment with a special focus on botulinum toxin injection. A PubMed search was performed to identify the literature using the search items diffuse esophageal spasm and treatment. Pharmacotherapy with smooth muscle relaxants, proton pump inhibitors, and antidepressants was suggested from small case series and uncontrolled clinical trials. Endoscopic injection of botulinum toxin is a well-studied treatment option and results in good symptomatic benefit in patients with diffuse esophageal spasm. Surgical treatment was reported in patients with very severe symptoms refractory to pharmacologic treatment. This article summarizes the present knowledge on the treatment of diffuse esophageal spasm with a special emphasis on botulinum toxin injection. Endoscopic injection of botulinum toxin is presently the best studied treatment option but many questions remain unanswered.
弥漫性食管痉挛是一种原发性食管动力障碍。在有吞咽困难的患者中,其患病率为 3-10%,且治疗选择有限。本文综述了弥漫性食管痉挛的治疗方法,包括药物治疗、内镜治疗和手术治疗,特别关注了肉毒毒素注射。通过使用弥漫性食管痉挛和治疗这两个检索词,在 PubMed 上进行了文献检索。平滑肌松弛剂、质子泵抑制剂和抗抑郁药的药物治疗来自于小病例系列和非对照临床试验。肉毒毒素内镜注射是一种研究充分的治疗选择,可使弥漫性食管痉挛患者获得良好的症状改善。对于对药物治疗有抗性的非常严重症状的患者,报告了手术治疗。本文总结了弥漫性食管痉挛的治疗现状,特别强调了肉毒毒素注射。内镜下肉毒毒素注射目前是研究最多的治疗选择,但仍有许多问题尚未得到解答。